Search Results

Pages

• Absence Management Policy

  Policy to support and manage matters relating to sickness absence. Provides a framework for managing and reporting ill-health.

  https://www.sabp.nhs.uk/aboutus/policies/workforce/workforce-0033

• Absence Management Policy

  To deal with matters relating to sickness absence of employees

  https://www.sabp.nhs.uk/aboutus/policies/workforce/workforce-0033/absence-management-policy

• Risk, Health, Safety & Wellbeing

  Includes: security, incident management, falls management

  https://www.sabp.nhs.uk/aboutus/policies/risk-health-safety-and-wellbeing

• Anti-Bullying and Harassment Policy

  Policy outlining principles of how to ensure bullying and harassment in the workplace is recognised and dealt with appropriately.

  https://www.sabp.nhs.uk/aboutus/policies/workforce/workforce0024-bullying-and-harassment-policy/bullying-harassment-pol

• Information Technology, Information Governance & Records Management

  Includes: FOI, information sharing, email & internet

  https://www.sabp.nhs.uk/aboutus/policies/digital-governance

• Advance Statement and Advance Decision Policy

  This policy refers to Advance Statements about a person's preferences of care, and Advance Decisions about the refusal of treatments. It also refers to Mental Capacity and Best Interests.

  https://www.sabp.nhs.uk/aboutus/policies/clinical/Clinical-AS

• Advance Statement and Advance Decision Policy

  Advance Statement and Advance Decision Policy The purpose of this policy is to ensure that care is consistence with the wishes of people who use services who may subsequently lack capacity.

  https://www.sabp.nhs.uk/aboutus/policies/clinical/Clinical-AS/advance-statements-policy

• Mental Capacity and Best Interests Policy

  Guidance for working with people who lack the capacity to make decisions - Mental Capacity Act (MCA)

  https://www.sabp.nhs.uk/aboutus/policies/mental-health-act-mental-capacity-act/mental-capacity

• The Atlas Study

  A pragmatic randomised double-blind trial of Antipsychotic Treatment of very Late-onset Schizophrenia-like psychosis.

  https://www.sabp.nhs.uk/research/current-studies/MHstudies/AtlasStudy

• The Observa Project

  An observational post-authorisation SCEM study to monitor the safety and utilisation of Asenapine (Sycrest) in the mental health trust setting.

  https://www.sabp.nhs.uk/research/current-studies/MHstudies/Observa